documents: FDA-2026-P-1300-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-1300-0007 FDA FDA-2026-P-1300 Attachment 2 - RLD BELSOMRA® (Suvorexant) Tablets 5 mg, 10 mg, 15 mg and 20 mg Approval Letter Supporting & Related Material Background Material 2026-02-27T05:00:00Z 2026 2     2026-02-27T23:33:00Z   0 0 09000064b91e3e1a

Links from other tables